Why This Biotech, Up 47%, Could Spark The Next Buyout Frenzy - Investor's Business Daily
Source:Investor's Business Daily
Xenon Pharmaceuticals stock launched Monday on “unprecedented” results.
Xenon Pharmaceuticals stock launched Monday on “unprecedented” results.